SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?


To: Richaaard who wrote (514)1/6/2000 8:58:00 AM
From: Hockeyfan  Read Replies (2) | Respond to of 1154
 
Genome Therapeutics Reports Financial Results for the First Quarter Of Fiscal 2000; Total Revenues Increase 18% from Previous Year; Net Loss in Fiscal 2000 ($0.01) Per Share vs. ($0.13) Per Share in Fiscal '99

biz.yahoo.com